Ozempic is not an inherently bad drug — it has genuine medical uses and life-changing potential for those who need it. But ...

Amy Schumer’s experience with Mounjaro has been vastly different from when she tried an alternative weight-loss medication ...

Recent research found that people taking semaglutide—the active ingredient in Ozempic and Wegovy—had more hair loss than ...

MIT scientists have created a method to "paint" GLP-1 drugs onto antibodies inside the body, achieving longer-lasting effects ...

Mounjaro, a weight loss drug launched by Eli Lilly in India, could be a game-changer and has been making waves lately. Here's ...

Ozempic is approved for the management of type 2 diabetes, but it’s also used off-label to support weight loss. You can get Ozempic only by prescription via a reputable telehealth platform or in ...

As research continues, Mounjaro may redefine medical weight loss strategies, but its ethical implications and long-term ...

BRP, identified through peptide prediction, may revolutionize weight loss treatment, offering efficacy without the ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

NanoPortal™ technology successfully delivers semaglutide, the active ingredient in Ozempic®/Wegovy®, in a preclinical study ...

And while there are no strong studies directly comparing the two, it seems like Mounjaro might be more effective for weight loss. Mounjaro and Ozempic are both diabetes drugs prescribed off-label ...

Another popular diabetes and weight-loss drug, Ozempic (semaglutide), manufactured by Novo Nordisk, has already established a ...